Budapest, Hungary

Agnes Stadler

This inventor holds 1 USPTO granted patent. Top assignee: Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt.. Active years: 1986.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Agnes Stadler. Retrieved from https://idiyas.com/inventor/agnes-stadler-dt4o5okr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 1986

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Agnes Stadler: Innovator in Pharmaceutical Chemistry

Introduction

Agnes Stadler is a prominent inventor based in Budapest, Hungary. She has made significant contributions to the field of pharmaceutical chemistry, particularly through her innovative work on dibenzo[bd]pyran derivatives. Her research has led to advancements that are crucial for various applications in medicine.

Latest Patents

Agnes Stadler holds 1 patent for her work on dibenzo[bd]pyran derivatives, which includes a process for the preparation of these compounds and their complexes with 2,6-di-O-methyl-beta-cyclodextrin. This patent showcases her expertise in creating complex chemical structures that have potential therapeutic benefits.

Career Highlights

Throughout her career, Agnes has been associated with Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt., a well-known pharmaceutical company. Her role at the company has allowed her to focus on research and development, contributing to the advancement of pharmaceutical products.

Collaborations

Agnes has collaborated with notable colleagues such as Mihaly Nogradi and Dezso Korbonits. These partnerships have enriched her research and have led to innovative solutions in the pharmaceutical industry.

Conclusion

Agnes Stadler's contributions to pharmaceutical chemistry through her patents and collaborations highlight her as a key figure in the field. Her work continues to influence the development of new medicinal compounds.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…